Related Experiment Video
Updated: Jul 9, 2026
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
New insights into PTEN
1UCSF Cancer Research Institute, 2340 Sutter Street, San Francisco, CA 94115, USA.
Abstract:
The functions ascribed to PTEN have become more diverse since its discovery as a putative phosphatase mutated in many human tumors. Although it can dephosphorylate lipids and proteins, it also has functions independent of phosphatase activity in normal and pathological states. In addition, control of PTEN function is very complex. It is positively and negatively regulated at the transcriptional level, as well as post-translationally by phosphorylation, ubiquitylation, oxidation and acetylation. Although most of its tumor suppressor activity is likely to be caused by lipid dephosphorylation at the plasma membrane, PTEN also resides in the cytoplasm and nucleus, and its subcellular distribution is under strict control. Deregulation of PTEN function is implicated in other human diseases in addition to cancer, including diabetes and autism.
Insights
PTEN (phosphatase and tensin homolog) is a tumor suppressor with diverse functions beyond dephosphorylation. Its complex regulation and subcellular localization are critical for normal cellular processes and implicated in diseases like cancer, diabetes, and autism.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- PTEN (phosphatase and tensin homolog) was initially identified as a tumor suppressor gene frequently mutated in human cancers.
- Its known functions extend beyond lipid and protein dephosphorylation, encompassing phosphatase-independent activities.
- PTEN's cellular roles are intricate, involving complex regulatory mechanisms and dynamic subcellular localization.
Purpose of the Study:
- To provide a comprehensive overview of PTEN's multifaceted functions.
- To elucidate the complex regulatory networks governing PTEN activity.
- To highlight PTEN's involvement in both cancerous and non-cancerous human diseases.
Main Methods:
- Literature review and synthesis of existing research on PTEN.
- Analysis of PTEN's biochemical activities, including phosphatase-dependent and -independent functions.
- Examination of PTEN's transcriptional and post-translational regulation (phosphorylation, ubiquitylation, oxidation, acetylation).
- Investigation of PTEN's subcellular localization (plasma membrane, cytoplasm, nucleus) and its implications.
Main Results:
- PTEN exhibits diverse functions, including lipid and protein dephosphorylation, as well as phosphatase-independent activities.
- PTEN function is tightly regulated at both transcriptional and post-translational levels.
- PTEN's subcellular distribution is dynamic and crucial for its diverse roles.
- Dysregulation of PTEN is implicated in a spectrum of diseases, including cancer, diabetes, and autism.
Conclusions:
- PTEN is a critical regulator with a broader functional repertoire than previously understood.
- Understanding PTEN's complex regulation and localization is key to deciphering its role in health and disease.
- Targeting PTEN pathways holds potential for therapeutic interventions in various human pathologies.
Related Concept Videos
01:23Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
01:22PI3K/mTOR/AKT Signaling Pathway